Furthermore, the interaction between the liver, adipose tissue, and pro-inflammatory molecules—such as interleukin-6 and tumor necrosis factor-alpha—released from activated macrophages and adipokines plays a crucial role in the progression of MASLD [34]. The gene discussed is IL6; the disease is metabolic dysfunction-associated steatotic liver disease.